Search results

• Methyldopa
  ...lase]], which converts [[L-DOPA|<small>L</small>-DOPA]] into [[dopamine]]. Dopamine is a precursor for [[norepinephrine]] (noradrenaline) and subsequently [[ep * It is converted to [[α-methylnorepinephrine]] by [[dopamine beta-hydroxylase]] (DBH). α-methylnorepinephrine is an [[agonist]] of pres
  8 KB (905 words) - 10:56, 20 September 2010
• Dopamine
  |ImageFile2=Dopamine-3d-CPK.png ...cyclopedia.com/doc/1O87-ventraltegmentalarea.html Reference for VTA.</ref> Dopamine is also a [[neurohormone]] released by the [[hypothalamus]]. Its main funct
  48 KB (6,470 words) - 16:48, 27 September 2010
• Ephedrine
  ...on of renal arteries. Also, difficulty urinating is not uncommon, as alpha-agonists such as ephedrine constrict the internal urethral sphincter, mimicking the ...mode of therapeutic action involves norepinephrine and to a lesser degree dopamine, but it also releases some serotonin from presynaptic clefts. It should not
  21 KB (2,906 words) - 16:51, 27 September 2010
• Diazepam
  ...5, 1985 | volume = 36| issue = 8| pages = 737–44| title = Effect of GABA agonists on the neurotoxicity and anticonvulsant activity of benzodiazepines| author ...}}</ref><ref name="Atack-2005"/> A single dose of diazepam modulates the [[dopamine]] system in similar ways to how morphine and [[ethanol|alcohol]] modulate t
  78 KB (10,295 words) - 16:51, 27 September 2010
• Template:Serotonergics
  | list1 = '''Agonists''': ''Azapirones'': [[Alnespirone]]{{•}} [[Binospirone]]{{•}} [[Buspiro | list2 = '''Agonists''': ''Lysergamides'': [[Dihydroergotamine]]{{•}} [[Ergotamine]]{{•}} [[
  26 KB (1,619 words) - 22:18, 21 September 2010
• Template:Antidepressants
  ...otonin-norepinephrine-dopamine reuptake inhibitor|Serotonin-norepinephrine-dopamine reuptake inhibitor]]s (SNDRIs)</small> | group5 = <small>[[Dopamine reuptake inhibitor|Dopamine reuptake inhibitor]]s (DRIs)</small>
  13 KB (1,038 words) - 16:53, 27 September 2010
• Template:Cannabinoids
  [[N-Arachidonoyl dopamine]] (NADA){{·w}} | group4 = Synthetic cannabinoid <br>receptor agonists
  6 KB (590 words) - 20:07, 21 September 2010
• Template:Cardiac stimulants excluding cardiac glycosides
  | group2 = [[Dopamine agonist]]s | list3 = [[Dopamine]] # • [[Dopexamine]] • [[Ibopamine]] • [[Octopamine]]
  2 KB (128 words) - 20:09, 21 September 2010
• Template:Antiemetics
  | group3 = [[Dopamine antagonist|D₂/D₃ Antagonist]]s
  2 KB (157 words) - 16:53, 27 September 2010
• Template:Adrenergics
  ...{•}} [[Anisodine]]{{•}} [[Cirazoline]]{{•}} [[Dipivefrine]]{{•}} [[Dopamine]]{{•}} [[Ephedrine]]{{•}} [[Epinephrine]] (Adrenaline){{•}} [[Etilefr ...edetomidine]]{{•}} [[Dihydroergotamine]]{{•}} [[Dipivefrine]]{{•}} [[Dopamine]]{{•}} [[Ephedrine]]{{•}} [[Ergotamine]]{{•}} [[Epinephrine]] (Adrena
  19 KB (1,075 words) - 16:53, 27 September 2010
• Template:Antihyperkinetics
  ...up8 = [[Dopamine receptor D1|Dopamine D1 receptor]] [[Dopamine D1 receptor#Agonists|agonist]]s | group9 = [[Alpha-7 nicotinic receptor|α7 nicotinic]] agonists / [[Allosteric modulation|PAM]]s
  3 KB (290 words) - 18:34, 19 September 2010
• Template:Hallucinogens
  ...''<small>[[5-HT2A_receptor|5-HT_2AR]] [[Serotonergic_psychedelic|agonists]]</small>'' | group2 = [[D2 receptor|D₂R]] [[Dopamine agonist|agonists]]
  11 KB (1,039 words) - 12:11, 19 September 2010
• Template:Antiparkinson
  | group1 = [[Dopamine|DA]] [[Precursor (chemistry)|precursor]]s/[[prodrug]]s | group2 = [[Dopamine receptor|DA receptor]] [[Dopamine receptor agonist|agonist]]s
  2 KB (152 words) - 16:45, 19 September 2010
• Template:Urologicals, including antispasmodics
  | group4 = [[Dopamine D4 receptor]] agonists
  2 KB (155 words) - 12:11, 19 September 2010
• Template:Dopaminergics
  | group1 = [[Dopamine receptor|Receptor]] [[ligand]]s | group1 = [[Dopamine receptor agonist|Agonists]]
  15 KB (871 words) - 01:22, 20 September 2010
• Ergotamine
  ...and [[norepinephrine]] receptors. It is its action on the [[D2 receptor|D2 dopamine]] and [[5HT1A|5-HT_1A receptor]]s that can cause some side effect {{Adrenergic agonists}}
  7 KB (986 words) - 13:14, 20 September 2010
• Octopamine
  ...octopamine is by β-[[hydroxylation]] of [[tyramine]] via the [[enzyme]] [[dopamine β-hydroxylase]]. Under the trade names '''Epirenor''', '''Norden''', and ' [[Category:Alpha-adrenergic agonists]]
  7 KB (980 words) - 13:14, 20 September 2010
• Phenylpropanolamine
  ...e]], or as a [[norepinephrine releasing agent]] (NRA). It also acts as a [[dopamine releasing agent]] (DRA) to a lesser extent. [[Category:Alpha-adrenergic agonists]]
  11 KB (1,420 words) - 13:15, 20 September 2010
• Analgesic
  ...no anticholinergic properties and is believed be devoid of any activity on dopamine, serotonin or histamin receptors. It is not addictive and tolerance does no ...eceptor antagonist), [[clonidine]] and other α₂-adrenoreceptor agonists, and [[mexiletine]] and other local anaesthetic analogues.
  14 KB (1,807 words) - 22:06, 21 September 2010
• Endocannabinoid system
  While there have been some papers that have linked concurrent stimulation of dopamine and CB1 receptors to an acute rise in cAMP production, it is accepted that ...ated changes to the membrane voltage have also been studied in detail. CB1 agonists reduce calcium influx by blocking the activity of voltage-dependent [[N-typ
  23 KB (3,059 words) - 22:08, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)